{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T09:17:45Z","timestamp":1789809465213,"version":"4.0.1"},"reference-count":214,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":402,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Dermatol"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1111\/bjd.12973","type":"journal-article","created":{"date-parts":[[2014,3,19]],"date-time":"2014-03-19T01:38:40Z","timestamp":1395193120000},"page":"220-233","source":"Crossref","is-referenced-by-count":18,"title":["Mechanisms of tumour vascularization in cutaneous malignant melanoma: clinical implications"],"prefix":"10.1093","volume":"171","author":[{"given":"I.","family":"Pastushenko","sequence":"first","affiliation":[{"name":"Department of Dermatology; Hospital Cl\u00ednico Universitario \u2018Lozano Blesa\u2019; Zaragoza 50009 Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.B.","family":"Vermeulen","sequence":"additional","affiliation":[{"name":"Translational Cancer Research Unit Antwerp; Oncology Centre; General Hospital Sint-Augustinus; Wilrijk 2610 Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.G.","family":"Van den Eynden","sequence":"additional","affiliation":[{"name":"Translational Cancer Research Unit Antwerp; Oncology Centre; General Hospital Sint-Augustinus; Wilrijk 2610 Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Rutten","sequence":"additional","affiliation":[{"name":"Translational Cancer Research Unit Antwerp; Oncology Centre; General Hospital Sint-Augustinus; Wilrijk 2610 Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.J.","family":"Carapeto","sequence":"additional","affiliation":[{"name":"Department of Medicine, Psychiatry and Dermatology; School of Medicine; University of Zaragoza; Zaragoza 50009 Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.Y.","family":"Dirix","sequence":"additional","affiliation":[{"name":"Translational Cancer Research Unit Antwerp; Oncology Centre; General Hospital Sint-Augustinus; Wilrijk 2610 Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Van Laere","sequence":"additional","affiliation":[{"name":"Translational Cancer Research Unit Antwerp; Oncology Centre; General Hospital Sint-Augustinus; Wilrijk 2610 Belgium"},{"name":"Department of Oncology; KU of Leuven; Herestraat 49 3000 Leuven Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2014,7,26]]},"reference":[{"key":"10.1111\/bjd.12973-BIB0001|bjd12973-cit-0001","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/CMR.0b013e328361926c","article-title":"Melanoma-related mortality and productivity losses in the U.S.A., 1990-2008","volume":"23","author":"Bristow","year":"2013","journal-title":"Melanoma Res"},{"key":"10.1111\/bjd.12973-BIB0002|bjd12973-cit-0002","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1111\/j.1365-2133.2012.11125.x","article-title":"Melanoma incidence and mortality in Europe: new estimates, persistent disparities","volume":"167","author":"Forsea","year":"2012","journal-title":"Br J Dermatol"},{"issue":"Suppl. 6","key":"10.1111\/bjd.12973-BIB0003|bjd12973-cit-0003","first-page":"vi1","article-title":"Epidemiology of invasive cutaneous melanoma","volume":"20","author":"MacKie","year":"2000","journal-title":"Ann Oncol"},{"key":"10.1111\/bjd.12973-BIB0004|bjd12973-cit-0004","doi-asserted-by":"crossref","first-page":"403","DOI":"10.6004\/jnccn.2012.0037","article-title":"Systemic therapy for metastatic melanoma in 2012: dawn of a new era","volume":"10","author":"Bhatia","year":"2012","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1111\/bjd.12973-BIB0005|bjd12973-cit-0005","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","article-title":"The hallmarks of cancer","volume":"100","author":"Hanahan","year":"2000","journal-title":"Cell"},{"key":"10.1111\/bjd.12973-BIB0006|bjd12973-cit-0006","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1046\/j.1087-0024.2000.00012.x","article-title":"Oncogenes and angiogenesis: signaling three-dimensional tumor growth","volume":"5","author":"Rak","year":"2000","journal-title":"J Investig Dermatol Symp Proc"},{"key":"10.1111\/bjd.12973-BIB0007|bjd12973-cit-0007","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.semcancer.2003.09.013","article-title":"Molecular regulation of angiogenesis and tumorigenesis by signal transduction pathways: evidence of predictable and reproducible patterns of synergy in diverse neoplasms","volume":"14","author":"Arbiser","year":"2004","journal-title":"Semin Cancer Biol"},{"key":"10.1111\/bjd.12973-BIB0008|bjd12973-cit-0008","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/ijc.11064","article-title":"Farnesyl transferase inhibitor SCH66336 is cytostatic, pro-apoptotic and enhances chemosensitivity to cisplatin in melanoma cells","volume":"105","author":"Smalley","year":"2003","journal-title":"Int J Cancer"},{"key":"10.1111\/bjd.12973-BIB0009|bjd12973-cit-0009","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1038\/jid.2010.297","article-title":"The farnesyl transferase inhibitor lonafarnib inhibits mTOR signaling and enforces sorafenib-induced apoptosis in melanoma cells","volume":"131","author":"Niessner","year":"2011","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.12973-BIB0010|bjd12973-cit-0010","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1073\/pnas.94.3.861","article-title":"Oncogenic H-ras stimulates tumor angiogenesis by two distinct pathways","volume":"94","author":"Arbiser","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/bjd.12973-BIB0011|bjd12973-cit-0011","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1172\/JCI30102","article-title":"Overexpression of Akt converts radial growth melanoma to vertical growth melanoma","volume":"117","author":"Govindarajan","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1111\/bjd.12973-BIB0012|bjd12973-cit-0012","doi-asserted-by":"crossref","first-page":"5743","DOI":"10.1158\/1078-0432.CCR-08-0405","article-title":"Tris(dibenzylideneacetone)dipalladium, a N-myristoyltransferase-1 inhibitor, is effective against melanoma growth in vitro and in vivo","volume":"14","author":"Bhandarkar","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1111\/bjd.12973-BIB0013|bjd12973-cit-0013","doi-asserted-by":"crossref","first-page":"9790","DOI":"10.1074\/jbc.M212929200","article-title":"Malignant transformation of melanocytes to melanoma by constitutive activation of mitogen-activated protein kinase kinase (MAPKK) signaling","volume":"278","author":"Govindarajan","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1111\/bjd.12973-BIB0014|bjd12973-cit-0014","first-page":"3728","article-title":"Mitogen-activated protein kinase activation is an early event in melanoma progression","volume":"8","author":"Cohen","year":"2002","journal-title":"Clin Cancer Res"},{"key":"10.1111\/bjd.12973-BIB0015|bjd12973-cit-0015","doi-asserted-by":"crossref","first-page":"7920","DOI":"10.1074\/jbc.M112210200","article-title":"A novel NF-\u03baB-inducing kinase-MAPK signaling pathway up-regulates NF-\u03baB activity in melanoma cells","volume":"277","author":"Dhawan","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1111\/bjd.12973-BIB0016|bjd12973-cit-0016","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s10555-005-1579-7","article-title":"Role of nuclear factor-\u03baB in melanoma","volume":"24","author":"Amiri","year":"2005","journal-title":"Cancer Metastasis Rev"},{"key":"10.1111\/bjd.12973-BIB0017|bjd12973-cit-0017","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1038\/nm.2846","article-title":"Pathological neoangiogenesis depends on oxidative stress regulation by ATM","volume":"18","author":"Okuno","year":"2012","journal-title":"Nat Med"},{"key":"10.1111\/bjd.12973-BIB0018|bjd12973-cit-0018","doi-asserted-by":"crossref","first-page":"5557","DOI":"10.1158\/1078-0432.CCR-12-1554","article-title":"Molecular pathways: inflammation-associated nitric-oxide production as a cancer-supporting redox mechanism and a potential therapeutic target","volume":"19","author":"Grimm","year":"2013","journal-title":"Clin Cancer Res"},{"key":"10.1111\/bjd.12973-BIB0019|bjd12973-cit-0019","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1172\/JCI118962","article-title":"Reactive oxygen intermediates increase vascular endothelial growth factor expression in vitro and in vivo","volume":"98","author":"Kuroki","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1111\/bjd.12973-BIB0020|bjd12973-cit-0020","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1097\/CMR.0b013e3282f1d2ec","article-title":"Melanoma vasculogenic mimicry is strongly related to reactive oxygen species level","volume":"17","author":"Vartanian","year":"2007","journal-title":"Melanoma Res"},{"key":"10.1111\/bjd.12973-BIB0021|bjd12973-cit-0021","doi-asserted-by":"crossref","first-page":"5132","DOI":"10.1038\/onc.2008.227","article-title":"Notch signaling regulates tumor angiogenesis by diverse mechanisms","volume":"27","author":"Dufraine","year":"2008","journal-title":"Oncogene"},{"key":"10.1111\/bjd.12973-BIB0022|bjd12973-cit-0022","doi-asserted-by":"crossref","first-page":"4182","DOI":"10.1158\/0008-5472.CAN-05-3589","article-title":"Notch1 signaling promotes primary melanoma progression by activating mitogen-activated protein kinase\/phosphatidylinositol 3-kinase-Akt pathways and up-regulating N-cadherin expression","volume":"66","author":"Liu","year":"2006","journal-title":"Cancer Res"},{"key":"10.1111\/bjd.12973-BIB0023|bjd12973-cit-0023","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1111\/pcmr.12131","article-title":"Notch signaling mediates melanoma-endothelial cell communication and melanoma cell migration","volume":"26","author":"Howard","year":"2013","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1111\/bjd.12973-BIB0024|bjd12973-cit-0024","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.canlet.2011.06.008","article-title":"Overexpression of Notch ligand Dll1 in B16 melanoma cells leads to reduced tumor growth due to attenuated vascularization","volume":"309","author":"Zhang","year":"2011","journal-title":"Cancer Lett"},{"key":"10.1111\/bjd.12973-BIB0025|bjd12973-cit-0025","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s10238-012-0190-9","article-title":"The involvement of Notch signaling in melanoma vasculogenic mimicry","volume":"13","author":"Vartanian","year":"2013","journal-title":"Clin Exp Med"},{"key":"10.1111\/bjd.12973-BIB0026|bjd12973-cit-0026","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1038\/sj.bjc.6603283","article-title":"Cellular senescence in naevi and immortalization in melanoma: a role for p16?","volume":"95","author":"Gray-Schopfer","year":"2006","journal-title":"Br J Cancer"},{"key":"10.1111\/bjd.12973-BIB0027|bjd12973-cit-0027","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1126\/science.7809631","article-title":"Inhibition of ras-induced proliferation and cellular transformation by p16INK4","volume":"267","author":"Serrano","year":"1995","journal-title":"Science"},{"key":"10.1111\/bjd.12973-BIB0028|bjd12973-cit-0028","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0092-8674(00)81902-9","article-title":"Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a","volume":"88","author":"Serrano","year":"1997","journal-title":"Cell"},{"key":"10.1111\/bjd.12973-BIB0029|bjd12973-cit-0029","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1038\/22788","article-title":"Essential role for oncogenic Ras in tumour maintenance","volume":"400","author":"Chin","year":"1999","journal-title":"Nature"},{"key":"10.1111\/bjd.12973-BIB0030|bjd12973-cit-0030","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1046\/j.1087-0024.2000.00007.x","article-title":"Regulation of angiogenesis and tumorigenesis by signal transduction cascades: lessons from benign and malignant endothelial tumor","volume":"5","author":"Flafter","year":"2000","journal-title":"J Invest Dermatol Symp Proc"},{"key":"10.1111\/bjd.12973-BIB0031|bjd12973-cit-0031","doi-asserted-by":"crossref","first-page":"5809","DOI":"10.1038\/onc.2010.314","article-title":"Somatic p16(INK4a) loss accelerates melanomagenesis","volume":"29","author":"Monahan","year":"2010","journal-title":"Oncogene"},{"key":"10.1111\/bjd.12973-BIB0032|bjd12973-cit-0032","doi-asserted-by":"crossref","first-page":"141236","DOI":"10.1155\/2012\/141236","article-title":"The role of PTEN in tumor angiogenesis","volume":"2012","author":"Rodr\u00edguez","year":"2012","journal-title":"J Oncol"},{"key":"10.1111\/bjd.12973-BIB0033|bjd12973-cit-0033","article-title":"PTEN functions as a melanoma tumor suppressor by promoting host immune response","author":"Dong","year":"2013","journal-title":"Oncogene"},{"key":"10.1111\/bjd.12973-BIB0034|bjd12973-cit-0034","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/jid.2009.213","article-title":"A mutated EGFR is sufficient to induce malignant melanoma with genetic background-dependent histopathologies","volume":"130","author":"Schartl","year":"2010","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.12973-BIB0035|bjd12973-cit-0035","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1158\/0008-5472.CAN-12-1681","article-title":"MDA-9\/syntenin and IGFBP-2 promote angiogenesis in human melanoma","volume":"73","author":"Das","year":"2013","journal-title":"Cancer Res"},{"key":"10.1111\/bjd.12973-BIB0036|bjd12973-cit-0036","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1038\/onc.2012.367","article-title":"GAB2 induces tumor angiogenesis in NRAS-driven melanoma","volume":"32","author":"Yang","year":"2013","journal-title":"Oncogene"},{"key":"10.1111\/bjd.12973-BIB0037|bjd12973-cit-0037","doi-asserted-by":"crossref","first-page":"E353","DOI":"10.1073\/pnas.1105026109","article-title":"Targeting oncogenic serine\/threonine-protein kinase BRAF in cancer cells inhibits angiogenesis and abrogates hypoxia","volume":"109","author":"Bottos","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/bjd.12973-BIB0038|bjd12973-cit-0038","doi-asserted-by":"crossref","first-page":"5558","DOI":"10.1158\/0008-5472.CAN-10-4543","article-title":"GPR56 regulates VEGF production and angiogenesis during melanoma progression","volume":"71","author":"Yang","year":"2011","journal-title":"Cancer Res"},{"key":"10.1111\/bjd.12973-BIB0039|bjd12973-cit-0039","doi-asserted-by":"crossref","first-page":"3367","DOI":"10.1172\/JCI35213","article-title":"Stat 3 mediates myeloid cell-dependent tumor angiogenesis in mice","volume":"118","author":"Kujawaski","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1111\/bjd.12973-BIB0040|bjd12973-cit-0040","first-page":"81","article-title":"Microvascular density, vascular endothelial growth factor immunoreactivity in tumours cells, vessel diameter and intussusceptive microvascular growth in primary melanoma","volume":"14","author":"Ribatti","year":"2005","journal-title":"Oncol Rep"},{"key":"10.1111\/bjd.12973-BIB0041|bjd12973-cit-0041","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/path.1124","article-title":"Vascularization of cutaneous melanoma involves vessel co-option and has clinical significance","volume":"197","author":"Dome","year":"2002","journal-title":"J Pathol"},{"key":"10.1111\/bjd.12973-BIB0042|bjd12973-cit-0042","first-page":"15","article-title":"Microcirculation patterns in different stages of melanoma growth","volume":"15","author":"Zhang","year":"2006","journal-title":"Oncol Rep"},{"key":"10.1111\/bjd.12973-BIB0043|bjd12973-cit-0043","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0002-9440(10)65173-5","article-title":"Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry","volume":"155","author":"Maniotis","year":"1999","journal-title":"Am J Pathol"},{"key":"10.1111\/bjd.12973-BIB0044|bjd12973-cit-0044","first-page":"6322","article-title":"Cooperative interactions of laminin 5 \u03b32 chain, matrix metalloproteinase-2 and membrane type-1-matrix\/metalloproteinase are required for mimicry of embryonic vasculogenesis by aggressive melanoma","volume":"61","author":"Seftor","year":"2001","journal-title":"Cancer Res"},{"key":"10.1111\/bjd.12973-BIB0045|bjd12973-cit-0045","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.ajpath.2012.07.013","article-title":"Tumor cell vasculogenic mimicry: from controversy to therapeutic promise","volume":"181","author":"Seftor","year":"2012","journal-title":"Am J Pathol"},{"key":"10.1111\/bjd.12973-BIB0046|bjd12973-cit-0046","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1089\/scd.2005.14.292","article-title":"Correlation between melanoma angiogenesis and the mesenchymal stem cells and endothelial progenitor cells derived from bone marrow","volume":"14","author":"Sun","year":"2005","journal-title":"Stem Cells Dev"},{"key":"10.1111\/bjd.12973-BIB0047|bjd12973-cit-0047","first-page":"172","article-title":"Expression of vascular permeability\/vascular endothelial growth factor by melanoma cells increases tumor growth, angiogenesis, and experimental metastasis","volume":"56","author":"Claffey","year":"1996","journal-title":"Cancer Res"},{"key":"10.1111\/bjd.12973-BIB0048|bjd12973-cit-0048","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1046\/j.1523-1747.2000.00199.x","article-title":"Human melanoma cells secrete and respond to placenta growth factor and vascular endothelial growth factor","volume":"115","author":"Lacal","year":"2000","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.12973-BIB0049|bjd12973-cit-0049","first-page":"308","article-title":"Basic fibroblast growth factor in human melanoma","volume":"3","author":"Rodeck","year":"1991","journal-title":"Cancer Cells"},{"key":"10.1111\/bjd.12973-BIB0050|bjd12973-cit-0050","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/00008390-199606000-00005","article-title":"Expression of FGF1 and FGFR1 in human melanoma tissues","volume":"6","author":"Xerri","year":"1996","journal-title":"Melanoma Res"},{"key":"10.1111\/bjd.12973-BIB0051|bjd12973-cit-0051","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1038\/jid.2011.177","article-title":"Fibroblast growth factor receptors as therapeutic targets in human melanoma: synergism with BRAF inhibition","volume":"131","author":"Metzner","year":"2011","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.12973-BIB0052|bjd12973-cit-0052","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/BF03402080","article-title":"Noninvasive dynamic fluorescence imaging of human melanomas reveals that targeted inhibition of bFGF or FGFR-1 in melanoma cells blocks tumor growth by apoptosis","volume":"8","author":"Valesky","year":"2002","journal-title":"Mol Med"},{"key":"10.1111\/bjd.12973-BIB0053|bjd12973-cit-0053","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1093\/carcin\/16.7.1499","article-title":"In situ analysis of transforming growth factor \u03b2s (TGF-\u03b21, TGF-\u03b22, TGF-\u03b23), and TGF-3 type II receptor expression in malignant melanoma","volume":"16","author":"Schmid","year":"1995","journal-title":"Carcinogenesis"},{"key":"10.1111\/bjd.12973-BIB0054|bjd12973-cit-0054","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1097\/00008390-200112000-00011","article-title":"Angiopoietin-1, angiopoietin-2 and Tie-2 in tumour and non-tumour tissues during growth of experimental melanoma","volume":"11","author":"Pomyje","year":"2001","journal-title":"Melanoma Res"},{"key":"10.1111\/bjd.12973-BIB0055|bjd12973-cit-0055","first-page":"4785","article-title":"Expression of interleukin 1 alpha, interleukin 6, and tumor necrosis factor alpha genes in human melanoma clones is associated with that of mutated N-RAS oncogene","volume":"54","author":"Castelli","year":"1994","journal-title":"Cancer Res"},{"key":"10.1111\/bjd.12973-BIB0056|bjd12973-cit-0056","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.4049\/jimmunol.151.5.2667","article-title":"IL-8 produced by human malignant melanoma cells in vitro is an essential autocrine growth factor","volume":"151","author":"Schadendorf","year":"1993","journal-title":"J Immunol"},{"key":"10.1111\/bjd.12973-BIB0057|bjd12973-cit-0057","first-page":"1105","article-title":"Expression of interleukin-8 by human melanoma cells up-regulates MMP-2 activity and increases tumor growth and metastasis","volume":"151","author":"Luca","year":"1997","journal-title":"Am J Pathol"},{"key":"10.1111\/bjd.12973-BIB0058|bjd12973-cit-0058","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.4049\/jimmunol.1202535","article-title":"Tumor-derived IL-35 promotes tumor growth by enhancing myeloid cell accumulation and angiogenesis","volume":"190","author":"Wang","year":"2013","journal-title":"J Immunol"},{"key":"10.1111\/bjd.12973-BIB0059|bjd12973-cit-0059","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.1038\/onc.2009.272","article-title":"A matrix metalloproteinase-1\/protease activated receptor-1 signaling axis promotes melanoma invasion and metastasis","volume":"28","author":"Blackburn","year":"2009","journal-title":"Oncogene"},{"key":"10.1111\/bjd.12973-BIB0060|bjd12973-cit-0060","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1046\/j.1523-1747.2000.00068.x","article-title":"Matrix metalloproteinases in human melanoma","volume":"115","author":"Hofmann","year":"2000","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.12973-BIB0061|bjd12973-cit-0061","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/sj.bjc.6690763","article-title":"Matrix metalloproteinases in human melanoma cell lines and xenografts: increased expression of activated matrix metalloproteinase-2 (MMP-2) correlates with melanoma progression","volume":"81","author":"Hofmann","year":"1999","journal-title":"Br J Cancer"},{"key":"10.1111\/bjd.12973-BIB0062|bjd12973-cit-0062","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ccr.2007.11.032","article-title":"Matrix metalloproteinase-9 is required for tumor vasculogenesis but not for angiogenesis: role of bone marrow-derived myelomonocytic cells","volume":"13","author":"Ahn","year":"2008","journal-title":"Cancer Cell"},{"key":"10.1111\/bjd.12973-BIB0063|bjd12973-cit-0063","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s10585-007-9136-0","article-title":"Tumoral and macrophage uPAR and MMP-9 contribute to the invasiveness of B16 murine melanoma cells","volume":"25","author":"Marconi","year":"2008","journal-title":"Clin Exp Metastasis"},{"key":"10.1111\/bjd.12973-BIB0064|bjd12973-cit-0064","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1177\/172460080502000407","article-title":"Collagenase-3 (MMP-13) expression in cutaneous malignant melanoma","volume":"20","author":"Corte","year":"2005","journal-title":"Int J Biol Markers"},{"key":"10.1111\/bjd.12973-BIB0065|bjd12973-cit-0065","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/ijc.10134","article-title":"Expression of membrane type 1 matrix metalloproteinase (MT1-MMP) in A2058 melanoma cells is associated with MMP-2 activation and increased tumor growth and vascularization","volume":"98","author":"Sounni","year":"2002","journal-title":"Int J Cancer"},{"key":"10.1111\/bjd.12973-BIB0066|bjd12973-cit-0066","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/00008390-200310000-00008","article-title":"Hypoxia-inducible factors 1\u03b1 and 2\u03b1 are related to vascular endothelial growth factor expression and a poorer prognosis in nodular malignant melanomas of the skin","volume":"13","author":"Giatromanolaki","year":"2003","journal-title":"Melanoma Res"},{"key":"10.1111\/bjd.12973-BIB0067|bjd12973-cit-0067","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0002-9440(10)61688-4","article-title":"Expression of vascular endothelial growth factor, its receptors (FLT-1; KDR) and TSP-1 related to microvessel density and patient outcome in vertical growth phase melanomas","volume":"159","author":"Straume","year":"2001","journal-title":"Am J Pathol"},{"key":"10.1111\/bjd.12973-BIB0068|bjd12973-cit-0068","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.humpath.2007.06.021","article-title":"Comparison of the prognostic value of matrix metalloproteinases 2 and 9 in cutaneous melanoma","volume":"39","author":"V\u00e4ls\u00e4nen","year":"2008","journal-title":"Hum Pathol"},{"key":"10.1111\/bjd.12973-BIB0069|bjd12973-cit-0069","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/j.1365-2133.2005.06507.x","article-title":"Circulating vascular endothelial growth factor in cutaneous malignant melanoma","volume":"152","author":"Pelletier","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.12973-BIB0070|bjd12973-cit-0070","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/00008390-200208000-00004","article-title":"VEGF-165 serum levels and tyrosinase expression in melanoma patients: correlation with the clinical course","volume":"12","author":"Osella-Abate","year":"2002","journal-title":"Melanoma Res"},{"key":"10.1111\/bjd.12973-BIB0071|bjd12973-cit-0071","first-page":"4255","article-title":"Prognostic value of serum VEGF in melanoma patients: a pilot study","volume":"24","author":"Ascierto","year":"2004","journal-title":"Anticancer Res"},{"key":"10.1111\/bjd.12973-BIB0072|bjd12973-cit-0072","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/j.1365-2133.2006.07724.x","article-title":"Early increase in serum levels of the angiogenesis-inhibitor endostatin and of basic fibroblast growth factor in melanoma patients during disease progression","volume":"156","author":"Kurschat","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.12973-BIB0073|bjd12973-cit-0073","first-page":"3211","article-title":"The role of circulating angiogenic factors in patients operated on for localized malignant melanoma","volume":"27","author":"Bolander","year":"2007","journal-title":"Anticancer Res"},{"key":"10.1111\/bjd.12973-BIB0074|bjd12973-cit-0074","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/01.cmr.0000222598.27438.82","article-title":"Circulating serum levels of angiogenic factors and vascular endothelial growth factor receptors 1 and 2 in melanoma patients","volume":"16","author":"Tas","year":"2006","journal-title":"Melanoma Res"},{"key":"10.1111\/bjd.12973-BIB0075|bjd12973-cit-0075","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s00403-012-1228-2","article-title":"A decreased ratio between serum levels of the antagonistic angiopoietins 1 and 2 indicates tumour progression of malignant melanoma","volume":"304","author":"Gardizi","year":"2012","journal-title":"Arch Dermatol Res"},{"key":"10.1111\/bjd.12973-BIB0076|bjd12973-cit-0076","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1038\/sj.bjc.6600315","article-title":"Intra-tumoural microvessel density in human solid tumours","volume":"86","author":"Hasan","year":"2002","journal-title":"Br J Cancer"},{"key":"10.1111\/bjd.12973-BIB0077|bjd12973-cit-0077","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/S0959-8049(02)00094-1","article-title":"Second international consensus on the methodology and criteria of evaluation of angiogenesis quantification in solid human tumours","volume":"38","author":"Vermeulen","year":"2002","journal-title":"Eur J Cancer"},{"key":"10.1111\/bjd.12973-BIB0078|bjd12973-cit-0078","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/PAP.0b013e3182691c2a","article-title":"Immunohistochemical endothelial markers: a review","volume":"19","author":"Ord\u00f3\u00f1ez","year":"2012","journal-title":"Adv Anat Pathol"},{"key":"10.1111\/bjd.12973-BIB0079|bjd12973-cit-0079","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM199101033240101","article-title":"Tumor angiogenesis and metastasis - correlation in invasive breast carcinoma","volume":"324","author":"Weidner","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1111\/bjd.12973-BIB0080|bjd12973-cit-0080","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/01.cmr.0000232291.68666.4c","article-title":"Proliferating endothelial cells, but not microvessel density, are a prognostic parameter in human cutaneous melanoma","volume":"16","author":"Hillen","year":"2006","journal-title":"Melanoma Res"},{"issue":"Suppl. 2","key":"10.1111\/bjd.12973-BIB0081|bjd12973-cit-0081","first-page":"S19","article-title":"Transition of horizontal to vertical growth phase melanoma is accompanied by induction of vascular endothelial growth factor expression and angiogenesis","volume":"7","author":"Erhard","year":"1997","journal-title":"Melanoma Res"},{"key":"10.1111\/bjd.12973-BIB0082|bjd12973-cit-0082","first-page":"99","article-title":"Regressing thin cutaneous malignant melanomas (\u22641.0\u00a0mm) are associated with angiogenesis","volume":"143","author":"Barnhill","year":"1993","journal-title":"Am J Pathol"},{"key":"10.1111\/bjd.12973-BIB0083|bjd12973-cit-0083","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/j.1600-0560.1997.tb01583.x","article-title":"Angiogenesis and malignant melanoma. Angiogenesis is related to the development of vertical (tumorigenic) growth phase","volume":"24","author":"Marcoval","year":"1997","journal-title":"J Cutan Pathol"},{"key":"10.1111\/bjd.12973-BIB0084|bjd12973-cit-0084","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/00008390-199906000-00009","article-title":"Prognostic value of tumour vascularity in primary melanoma","volume":"9","author":"Ilmonen","year":"1999","journal-title":"Melanoma Res"},{"key":"10.1111\/bjd.12973-BIB0085|bjd12973-cit-0085","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s10434-999-0070-z","article-title":"Angiogenesis correlates with metastasis in melanoma","volume":"6","author":"Neitzel","year":"1999","journal-title":"Ann Surg Oncol"},{"key":"10.1111\/bjd.12973-BIB0086|bjd12973-cit-0086","first-page":"595","article-title":"Angiogenesis is prognostically important in vertical growth phase melanomas","volume":"15","author":"Straume","year":"1999","journal-title":"Int J Oncol"},{"key":"10.1111\/bjd.12973-BIB0087|bjd12973-cit-0087","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/bjc.1991.250","article-title":"The vascularity of cutaneous melanoma: a quantitative histological study of lesions 0.85-1.25\u00a0mm in thickness","volume":"64","author":"Carnochan","year":"1991","journal-title":"Br J Cancer"},{"key":"10.1111\/bjd.12973-BIB0088|bjd12973-cit-0088","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/S0140-6736(94)90557-6","article-title":"Tumour vascularity is not a prognostic factor for cutaneous melanoma","volume":"344","author":"Barnhill","year":"1994","journal-title":"Lancet"},{"key":"10.1111\/bjd.12973-BIB0089|bjd12973-cit-0089","first-page":"510","article-title":"Extent of vascularization as a prognostic indicator in thin (< 0.76\u00a0mm) malignant melanomas","volume":"145","author":"Graham","year":"1994","journal-title":"Am J Pathol"},{"key":"10.1111\/bjd.12973-BIB0090|bjd12973-cit-0090","first-page":"1049","article-title":"Tumor vascularity is not a prognostic factor for malignant melanoma of the skin","volume":"147","author":"Busam","year":"1995","journal-title":"Am J Pathol"},{"key":"10.1111\/bjd.12973-BIB0091|bjd12973-cit-0091","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1600-0560.1995.tb01393.x","article-title":"Immunohistochemical assessment of tumor vascularity in recurrent Clark II melanomas using antibody to type IV collagen","volume":"22","author":"Guffey","year":"1995","journal-title":"J Cutan Pathol"},{"key":"10.1111\/bjd.12973-BIB0092|bjd12973-cit-0092","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1111\/j.1365-2133.1996.tb07001.x","article-title":"Vascular density and survival in cutaneous melanoma","volume":"134","author":"Marcoval","year":"1996","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.12973-BIB0093|bjd12973-cit-0093","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1200\/JCO.2002.07.082","article-title":"Tumor vascularity in the prognostic assessment of primary cutaneous melanoma","volume":"20","author":"Kashani-Sabet","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1111\/bjd.12973-BIB0094|bjd12973-cit-0094","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.ejca.2003.09.009","article-title":"Selective immunohistochemical staining shows significant prognostic influence of lymphatic and blood vessels in patients with malignant melanoma","volume":"40","author":"Valencak","year":"2004","journal-title":"Eur J Cancer"},{"key":"10.1111\/bjd.12973-BIB0095|bjd12973-cit-0095","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/j.1365-2559.2005.02193.x","article-title":"Microvessel density for melanoma prognosis","volume":"47","author":"Depasquale","year":"2005","journal-title":"Histopathology"},{"key":"10.1111\/bjd.12973-BIB0096|bjd12973-cit-0096","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1080\/00313020600557565","article-title":"The correlation of angiogenesis with metastasis in primary cutaneous melanoma: a comparative analysis of microvessel density, expression of vascular endothelial growth factor and basic fibroblastic growth factor","volume":"38","author":"Demirkessen","year":"2006","journal-title":"Pathology"},{"key":"10.1111\/bjd.12973-BIB0097|bjd12973-cit-0097","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/bjd.12688","article-title":"Blood microvessel density, lymphatic microvessel density and lymphatic invasion in predicting melanoma metastases: systematic review and meta-analysis","volume":"170","author":"Pastushenko","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.12973-BIB0098|bjd12973-cit-0098","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.0022-202X.2005.23830.x","article-title":"Thalidomide enhances the anti-tumor activity of standard chemotherapy in a human melanoma xenotransplantation model","volume":"125","author":"Heere-Ress","year":"2005","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.12973-BIB0099|bjd12973-cit-0099","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s10555-008-9147-6","article-title":"Non-invasive assessment of tumor neovasculature: techniques and clinical applications","volume":"27","author":"Perini","year":"2008","journal-title":"Cancer Metastasis Rev"},{"key":"10.1111\/bjd.12973-BIB0100|bjd12973-cit-0100","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/CMR.0b013e32834941d3","article-title":"Circulating levels of VEGFR-1 and VEGFR-2 in patients with metastatic melanoma treated with chemoimmunotherapy alone or combined with bevacizumab","volume":"21","author":"Vihinen","year":"2011","journal-title":"Melanoma Res"},{"key":"10.1111\/bjd.12973-BIB0101|bjd12973-cit-0101","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.ccr.2005.09.005","article-title":"Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors","volume":"8","author":"Casanovas","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1111\/bjd.12973-BIB0102|bjd12973-cit-0102","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.ccr.2009.01.021","article-title":"Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis","volume":"15","author":"Ebos","year":"2009","journal-title":"Cancer Cell"},{"key":"10.1111\/bjd.12973-BIB0103|bjd12973-cit-0103","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.ccr.2009.01.027","article-title":"Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis","volume":"15","author":"P\u00e0ez-Ribes","year":"2009","journal-title":"Cancer Cell"},{"key":"10.1111\/bjd.12973-BIB0104|bjd12973-cit-0104","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1038\/sj.onc.1209273","article-title":"Hypoxia stimulates breast carcinoma cell invasion through MT1-MMP and MMP-2 activation","volume":"25","author":"Mu\u00f1oz-N\u00e1jar","year":"2006","journal-title":"Oncogene"},{"key":"10.1111\/bjd.12973-BIB0105|bjd12973-cit-0105","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1158\/2159-8290.CD-11-0240","article-title":"Suppression of tumor invasion and metastasis by concurrent inhibition of c-Met and VEGF signaling in pancreatic neuroendocrine tumors","volume":"2","author":"Sennino","year":"2012","journal-title":"Cancer Discov"},{"key":"10.1111\/bjd.12973-BIB0106|bjd12973-cit-0106","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1038\/nature05355","article-title":"Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis","volume":"444","author":"Noguera-Troise","year":"2006","journal-title":"Nature"},{"key":"10.1111\/bjd.12973-BIB0107|bjd12973-cit-0107","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1002\/1097-0142(20010415)91:8<1500::AID-CNCR1158>3.0.CO;2-M","article-title":"Patterns of angiogenesis in nonsmall-cell lung carcinoma","volume":"91","author":"Offersen","year":"2001","journal-title":"Cancer"},{"key":"10.1111\/bjd.12973-BIB0108|bjd12973-cit-0108","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.1002\/cncr.26540","article-title":"Mechanisms of resistance to vascular endothelial growth factor blockade","volume":"118","author":"Abdullah","year":"2012","journal-title":"Cancer"},{"key":"10.1111\/bjd.12973-BIB0109|bjd12973-cit-0109","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s10555-007-9068-9","article-title":"Chemokines in tumor angiogenesis and metastasis","volume":"26","author":"Singh","year":"2007","journal-title":"Cancer Metastasis Rev"},{"key":"10.1111\/bjd.12973-BIB0110|bjd12973-cit-0110","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/CMR.0b013e3283543d72","article-title":"Interleukin-6 and melanoma","volume":"22","author":"Hoejberg","year":"2012","journal-title":"Melanoma Res"},{"key":"10.1111\/bjd.12973-BIB0111|bjd12973-cit-0111","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1038\/nbt1323","article-title":"Tumor refractoriness to anti-VEGF treatment is mediated by CD11b+Gr1+","volume":"25","author":"Shojaei","year":"2007","journal-title":"Nat Biotechnol"},{"key":"10.1111\/bjd.12973-BIB0112|bjd12973-cit-0112","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/nrclinonc.2011.21","article-title":"Antiangiogenic therapy: impact on invasion, disease progression, and metastasis","volume":"8","author":"Ebos","year":"2011","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1111\/bjd.12973-BIB0113|bjd12973-cit-0113","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.cell.2011.08.039","article-title":"Basic and therapeutic aspects of angiogenesis","volume":"146","author":"Potente","year":"2011","journal-title":"Cell"},{"key":"10.1111\/bjd.12973-BIB0114|bjd12973-cit-0114","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1038\/nrc1478","article-title":"Why do cancers have high aerobic glycolysis?","volume":"4","author":"Gatenby","year":"2004","journal-title":"Nat Rec Cancer"},{"key":"10.1111\/bjd.12973-BIB0115|bjd12973-cit-0115","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s10585-008-9145-7","article-title":"Acid treatment of melanoma cells selects for invasive phenotypes","volume":"25","author":"Moellering","year":"2008","journal-title":"Clin Exp Metastasis"},{"key":"10.1111\/bjd.12973-BIB0116|bjd12973-cit-0116","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1007\/BF00121214","article-title":"Acidic pH enhances the invasive behaviour of human melanoma cells","volume":"14","author":"Mart\u00ednez-Zaguil\u00e1n","year":"1996","journal-title":"Clin Exp Metastasis"},{"key":"10.1111\/bjd.12973-BIB0117|bjd12973-cit-0117","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/jcp.21494","article-title":"Tumor lymphangiogenesis and melanoma metastasis","volume":"216","author":"Rinderknecht","year":"2008","journal-title":"J Cell Physiol"},{"key":"10.1111\/bjd.12973-BIB0118|bjd12973-cit-0118","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1084\/jem.20041896","article-title":"VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis","volume":"201","author":"Hirakawa","year":"2005","journal-title":"J Exp Med"},{"key":"10.1111\/bjd.12973-BIB0119|bjd12973-cit-0119","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1182\/blood-2006-05-021758","article-title":"VEGF-C-induced lymphangiogenesis in sentinel lymph nodes promotes tumor metastasis to distant sites","volume":"109","author":"Hirakawa","year":"2007","journal-title":"Blood"},{"key":"10.1111\/bjd.12973-BIB0120|bjd12973-cit-0120","doi-asserted-by":"crossref","first-page":"5391","DOI":"10.1158\/1078-0432.CCR-07-1230","article-title":"Increased sentinel lymph node lymphangiogenesis is associated with nonsentinel axillary lymph node involvement in breast cancer patients with a positive sentinel node","volume":"13","author":"Eynden","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1111\/bjd.12973-BIB0121|bjd12973-cit-0121","doi-asserted-by":"crossref","first-page":"774","DOI":"10.2353\/ajpath.2007.060761","article-title":"Tumor-induced sentinel lymph node lymphangiogenesis and increased lymph flow precede melanoma metastasis","volume":"170","author":"Harrell","year":"2007","journal-title":"Am J Pathol"},{"key":"10.1111\/bjd.12973-BIB0122|bjd12973-cit-0122","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1038\/modpathol.3800410","article-title":"Tumor lymphangiogenesis predicts melanoma metastasis to sentinel lymph nodes","volume":"18","author":"Dadras","year":"2005","journal-title":"Mod Pathol"},{"key":"10.1111\/bjd.12973-BIB0123|bjd12973-cit-0123","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/35020115","article-title":"Molecular classification of cutaneous malignant melanoma by gene expression profiling","volume":"406","author":"Bittner","year":"2000","journal-title":"Nature"},{"key":"10.1111\/bjd.12973-BIB0124|bjd12973-cit-0124","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1093\/jnci\/djj103","article-title":"Gene expression profiling of primary cutaneous melanoma and clinical outcome","volume":"98","author":"Winnepenninckx","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"10.1111\/bjd.12973-BIB0125|bjd12973-cit-0125","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/bjc.2013.688","article-title":"Role of EIF5A2, a downstream target of Akt, in promoting melanoma cell invasion","volume":"110","author":"Khosravi","year":"2014","journal-title":"Br J Cancer"},{"key":"10.1111\/bjd.12973-BIB0126|bjd12973-cit-0126","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1158\/0008-5472.CAN-05-3387","article-title":"Tumor endothelial cells express epidermal growth factor receptor (EGFR) but not ErbB3 and are responsive to EGF and to EGFR kinase inhibitors","volume":"66","author":"Amin","year":"2006","journal-title":"Cancer Res"},{"key":"10.1111\/bjd.12973-BIB0127|bjd12973-cit-0127","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1158\/1541-7786.MCR-08-0215","article-title":"Tie2 tumor endothelial signaling and survival: implications for antiangiogenic therapy","volume":"7","author":"Tsai","year":"2009","journal-title":"Mol Cancer Res"},{"key":"10.1111\/bjd.12973-BIB0128|bjd12973-cit-0128","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1091\/mbc.E11-11-0934","article-title":"Identification of IGPR-1 as a novel adhesion molecule involved in angiogenesis","volume":"23","author":"Rahimi","year":"2012","journal-title":"Mol Biol Cell"},{"key":"10.1111\/bjd.12973-BIB0129|bjd12973-cit-0129","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/cam4.28","article-title":"Modulation of CXCL-8 expression in human melanoma cells regulates tumor growth, angiogenesis, invasion, and metastasis","volume":"1","author":"Wu","year":"2012","journal-title":"Cancer Med"},{"key":"10.1111\/bjd.12973-BIB0130|bjd12973-cit-0130","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.humpath.2009.08.016","article-title":"Quantitative expression of VEGF, VEGF-R1, VEGF-R2, and VEGF-R3 in melanoma tissue microarrays","volume":"41","author":"Mehnert","year":"2010","journal-title":"Hum Pathol"},{"key":"10.1111\/bjd.12973-BIB0131|bjd12973-cit-0131","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/sj.bjc.6600052","article-title":"Hypoxia-associated spontaneous pulmonary metastasis in human melanoma xenografts: involvement of microvascular hot spots induced in hypoxic foci by interleukin 8","volume":"86","author":"Rofstad","year":"2002","journal-title":"Br J Cancer"},{"key":"10.1111\/bjd.12973-BIB0132|bjd12973-cit-0132","doi-asserted-by":"crossref","first-page":"10849","DOI":"10.1158\/0008-5472.CAN-07-1791","article-title":"RNA interference inhibition of matrix metalloproteinase-1 prevents melanoma metastasis by reducing tumor collagenase activity and angiogenesis","volume":"67","author":"Blackburn","year":"2007","journal-title":"Cancer Res"},{"key":"10.1111\/bjd.12973-BIB0133|bjd12973-cit-0133","doi-asserted-by":"crossref","first-page":"e11241","DOI":"10.1371\/journal.pone.0011241","article-title":"Endothelin-1 inhibits prolyl hydroxylase domain 2 to activate hypoxia-inducible factor-1\u03b1 in melanoma cells","volume":"5","author":"Spinella","year":"2010","journal-title":"PLOS ONE"},{"key":"10.1111\/bjd.12973-BIB0134|bjd12973-cit-0134","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.bbrc.2013.03.051","article-title":"Hypoxia-inducible factor-1\u03b2 (HIF-1\u03b2) is upregulated in a HIF-1\u03b1-dependent manner in 518A2 human melanoma cells under hypoxic conditions","volume":"434","author":"Mandl","year":"2013","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1111\/bjd.12973-BIB0135|bjd12973-cit-0135","first-page":"721","article-title":"Slit3 inhibits activator protein 1-mediated migration of malignant melanoma cells","volume":"28","author":"Denk","year":"2011","journal-title":"Int J Mol Med"},{"key":"10.1111\/bjd.12973-BIB0136|bjd12973-cit-0136","doi-asserted-by":"crossref","first-page":"2984","DOI":"10.1038\/onc.2012.307","article-title":"Micro-RNA miR-125b controls melanoma progression by direct regulation of c-Jun protein expression","volume":"32","author":"Kappelmann","year":"2013","journal-title":"Oncogene"},{"key":"10.1111\/bjd.12973-BIB0137|bjd12973-cit-0137","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1093\/jnci\/djh120","article-title":"Effect of deoxyribozymes targeting c-Jun on solid tumor growth and angiogenesis in rodents","volume":"96","author":"Zhang","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"10.1111\/bjd.12973-BIB0138|bjd12973-cit-0138","doi-asserted-by":"crossref","first-page":"45651","DOI":"10.1074\/jbc.M301373200","article-title":"Mechanisms of hypoxic gene regulation of angiogenesis factor Cyr61 in melanoma cells","volume":"278","author":"Kunz","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1111\/bjd.12973-BIB0139|bjd12973-cit-0139","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1074\/jbc.M109.075630","article-title":"c-Jun regulates phosphoinositide-dependent kinase 1 transcription: implication for Akt and protein kinase C activities and melanoma tumorigenesis","volume":"285","author":"Lopez-Bergami","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1111\/bjd.12973-BIB0140|bjd12973-cit-0140","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/CMR.0b013e328184451e","article-title":"The 18\u00a0kDa isoform of basic fibroblast growth factor is sufficient to stimulate human melanoma growth and angiogenesis","volume":"17","author":"Fontijn","year":"2007","journal-title":"Melanoma Res"},{"key":"10.1111\/bjd.12973-BIB0141|bjd12973-cit-0141","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.cyto.2005.03.008","article-title":"Selective induction of interleukin-8 expression in metastatic melanoma cells by transforming growth factor-\u03b21","volume":"31","author":"Liu","year":"2005","journal-title":"Cytokine"},{"key":"10.1111\/bjd.12973-BIB0142|bjd12973-cit-0142","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.mvr.2009.06.010","article-title":"The EGFR inhibitor gefitinib suppresses recruitment of pericytes and bone marrow-derived perivascular cells into tumor vessels","volume":"78","author":"Iivanainen","year":"2009","journal-title":"Microvasc Res"},{"key":"10.1111\/bjd.12973-BIB0143|bjd12973-cit-0143","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1158\/1078-0432.CCR-06-0776","article-title":"c-Met is a potentially new therapeutic target for treatment of human melanoma","volume":"13","author":"Puri","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1111\/bjd.12973-BIB0144|bjd12973-cit-0144","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1755-148X.2010.00804.x","article-title":"Stress-sensing toll-like receptor as a driver of angiogenesis","volume":"24","author":"Wang","year":"2011","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1111\/bjd.12973-BIB0145|bjd12973-cit-0145","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1038\/nature09421","article-title":"Oxidative stress induces angiogenesis by activating TLR2 with novel endogenous ligands","volume":"467","author":"West","year":"2010","journal-title":"Nature"},{"key":"10.1111\/bjd.12973-BIB0146|bjd12973-cit-0146","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1038\/onc.2011.427","article-title":"NF-\u03baB inducing kinase (NIK) modulates melanoma tumorigenesis by regulating expression of pro-survival factors through the \u03b2-catenin pathway","volume":"31","author":"Thu","year":"2012","journal-title":"Oncogene"},{"key":"10.1111\/bjd.12973-BIB0147|bjd12973-cit-0147","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.2353\/ajpath.2006.050711","article-title":"Inhibition of tumor endothelial ERK activation, angiogenesis, and tumor growth by sorafenib (BAY43-9006)","volume":"169","author":"Murphy","year":"2006","journal-title":"Am J Pathol"},{"key":"10.1111\/bjd.12973-BIB0148|bjd12973-cit-0148","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.2741\/1643","article-title":"Involvement of phospholipase C signaling in melanoma cell-induced endothelial junction disassembly","volume":"10","author":"Peng","year":"2005","journal-title":"Front Biosci"},{"key":"10.1111\/bjd.12973-BIB0149|bjd12973-cit-0149","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1152\/ajpcell.00242.2009","article-title":"p38 MAP kinase is necessary for melanoma-mediated regulation of VE-cadherin disassembly","volume":"298","author":"Khanna","year":"2010","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1111\/bjd.12973-BIB0150|bjd12973-cit-0150","article-title":"Endothelial deletion of Sag\/Rbx2\/Roc2 E3 ubiquitin ligase causes embryonic lethality and blocks tumor angiogenesis","author":"Tan","year":"2013","journal-title":"Oncogene"},{"key":"10.1111\/bjd.12973-BIB0151|bjd12973-cit-0151","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1182\/blood-2004-06-2246","article-title":"Tumor metastasis but not tumor growth is dependent on Src-mediated vascular permeability","volume":"105","author":"Criscuoli","year":"2005","journal-title":"Blood"},{"key":"10.1111\/bjd.12973-BIB0152|bjd12973-cit-0152","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1007\/s10456-013-9368-3","article-title":"Human proangiogenic circulating hematopoietic stem and progenitor cells promote tumor growth in an orthotopic melanoma xenograft model","volume":"16","author":"Mund","year":"2013","journal-title":"Angiogenesis"},{"key":"10.1111\/bjd.12973-BIB0153|bjd12973-cit-0153","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s10456-012-9323-8","article-title":"The stem cell marker prominin-1\/CD133 interacts with vascular endothelial growth factor and potentiates its action","volume":"16","author":"Adini","year":"2013","journal-title":"Angiogenesis"},{"key":"10.1111\/bjd.12973-BIB0154|bjd12973-cit-0154","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S1535-6108(02)00153-8","article-title":"MMP9 induction by vascular endothelial growth factor receptor-1 is involved in lung-specific metastasis","volume":"2","author":"Hiratsuka","year":"2002","journal-title":"Cancer Cell"},{"key":"10.1111\/bjd.12973-BIB0155|bjd12973-cit-0155","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/CMR.0b013e328343a237","article-title":"VEGFR1 and PKC\u03b1 signaling control melanoma vasculogenic mimicry in a VEGFR2 kinase-independent manner","volume":"21","author":"Vartanian","year":"2011","journal-title":"Melanoma Res"},{"key":"10.1111\/bjd.12973-BIB0156|bjd12973-cit-0156","first-page":"3185","article-title":"Two independent mechanisms for tumor angiogenesis: inhibition of human melanoma xenograft growth by interfering with either the vascular endothelial growth factor receptor pathway or the Tie-2 pathway","volume":"59","author":"Siemeister","year":"1999","journal-title":"Cancer Res"},{"key":"10.1111\/bjd.12973-BIB0157|bjd12973-cit-0157","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1038\/sj.bjc.6690586","article-title":"Hypoxia-induced metastasis of human melanoma cells: involvement of vascular endothelial growth factor-mediated angiogenesis","volume":"80","author":"Rofstad","year":"1999","journal-title":"Br J Cancer"},{"key":"10.1111\/bjd.12973-BIB0158|bjd12973-cit-0158","first-page":"4932","article-title":"Vascular endothelial growth factor, interleukin 8, platelet-derived endothelial cell growth factor, and basic fibroblast growth factor promote angiogenesis and metastasis in human melanoma xenografts","volume":"60","author":"Rofstad","year":"2000","journal-title":"Cancer Res"},{"key":"10.1111\/bjd.12973-BIB0159|bjd12973-cit-0159","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1046\/j.1523-1747.2000.00022.x","article-title":"Expression patterns of placenta growth factor in human melanocytic cell lines","volume":"115","author":"Graeven","year":"2000","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.12973-BIB0160|bjd12973-cit-0160","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.3892\/or.2013.2791","article-title":"Platelet-derived growth factor C and calpain-3 are modulators of human melanoma cell invasiveness","volume":"30","author":"Ruffini","year":"2013","journal-title":"Oncol Rep"},{"key":"10.1111\/bjd.12973-BIB0161|bjd12973-cit-0161","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/1471-2407-7-224","article-title":"Platelet-derived growth factor receptor-\u03b2, carrying the activating mutation D849N, accelerates the establishment of B16 melanoma","volume":"7","author":"Suzuki","year":"2007","journal-title":"BMC Cancer"},{"key":"10.1111\/bjd.12973-BIB0162|bjd12973-cit-0162","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1158\/0008-5472.CAN-03-1489","article-title":"Platelet-derived growth factor production by B16 melanoma cells leads to increased pericyte abundance in tumors and an associated increase in tumor growth rate","volume":"64","author":"Furuhashi","year":"2004","journal-title":"Cancer Res"},{"key":"10.1111\/bjd.12973-BIB0163|bjd12973-cit-0163","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1046\/j.1365-2133.1996.d01-1092.x","article-title":"Expression of platelet-derived growth factor (PDGF)-A, PDGF-B and the PDGF-\u03b1 receptor, but not the PDGF-\u03b2 receptor, in human malignant melanoma in vivo","volume":"135","author":"Barnhill","year":"1996","journal-title":"Br J Dermatol"},{"key":"10.1111\/bjd.12973-BIB0164|bjd12973-cit-0164","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/S0959-8049(02)00150-8","article-title":"Neovascularisation, expression of fibroblast growth factor-2, and mast cells with tryptase activity increase simultaneously with pathological progression in human malignant melanoma","volume":"39","author":"Ribatti","year":"2003","journal-title":"Eur J Cancer"},{"key":"10.1111\/bjd.12973-BIB0165|bjd12973-cit-0165","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/(SICI)1097-0215(20000115)85:2%3C182::AID-IJC6%3E3.0.CO;2-M","article-title":"Macrophage infiltration correlates with tumor stage and angiogenesis in human malignant melanoma: possible involvement of TNF\u03b1 and IL-1\u03b1","volume":"85","author":"Torisu","year":"2000","journal-title":"Int J Cancer"},{"key":"10.1111\/bjd.12973-BIB0166|bjd12973-cit-0166","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1172\/JCI58832","article-title":"Angiopoietin-2 differentially regulates angiogenesis through TIE2 and integrin signaling","volume":"122","author":"Felcht","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1111\/bjd.12973-BIB0167|bjd12973-cit-0167","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1073\/pnas.0437939100","article-title":"IL-1 is required for tumor invasiveness and angiogenesis","volume":"100","author":"Voronov","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/bjd.12973-BIB0168|bjd12973-cit-0168","doi-asserted-by":"crossref","first-page":"6477","DOI":"10.1074\/jbc.M109.064907","article-title":"Constitutively active inflammasome in human melanoma cells mediating autoinflammation via caspase-1 processing and secretion of interleukin-1\u03b2","volume":"285","author":"Okamoto","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1111\/bjd.12973-BIB0169|bjd12973-cit-0169","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1158\/1078-0432.CCR-05-1603","article-title":"The role of interleukin 1 in growth and metastasis of human cancer xenografts","volume":"12","author":"Elaraj","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1111\/bjd.12973-BIB0170|bjd12973-cit-0170","doi-asserted-by":"crossref","first-page":"3500","DOI":"10.4049\/jimmunol.1202769","article-title":"The role of IL-1\u03b2 in the early tumor cell-induced angiogenic response","volume":"190","author":"Carmi","year":"2013","journal-title":"J Immunol"},{"key":"10.1111\/bjd.12973-BIB0171|bjd12973-cit-0171","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1002\/ijc.23973","article-title":"Nuclear factor kappa B subunit p50 promotes melanoma angiogenesis by upregulating interleukin-6 expression","volume":"124","author":"Karst","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1111\/bjd.12973-BIB0172|bjd12973-cit-0172","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.4049\/jimmunol.170.6.3369","article-title":"IL-8 directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinases production and regulated angiogenesis","volume":"170","author":"Li","year":"2003","journal-title":"J Immunol"},{"key":"10.1111\/bjd.12973-BIB0173|bjd12973-cit-0173","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.ajpath.2012.04.012","article-title":"Highly invasive melanoma cells activate the vascular endothelium via MMP-2\/integrin \u03b1v\u03b25-induced secretion of VEGF-A","volume":"181","author":"Desch","year":"2012","journal-title":"Am J Pathol"},{"key":"10.1111\/bjd.12973-BIB0174|bjd12973-cit-0174","article-title":"A novel matrix metalloproteinase-2 inhibitor triazolylmethyl aziridine reduces melanoma cell invasion, angiogenesis and targets ERK1\/2 phosphorylation","author":"Romanchikova","year":"2013","journal-title":"J Enzyme Inhib Med Chem"},{"key":"10.1111\/bjd.12973-BIB0175|bjd12973-cit-0175","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1038\/jid.2009.130","article-title":"Stromal expression of MMP-13 is required for melanoma invasion and metastasis","volume":"129","author":"Zigrino","year":"2009","journal-title":"J Invest Dermatol"},{"key":"10.1111\/bjd.12973-BIB0176|bjd12973-cit-0176","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1096\/fj.01-0790com","article-title":"MT1-MMP expression promotes tumor growth and angiogenesis through an up-regulation of vascular endothelial growth factor expression","volume":"16","author":"Sounni","year":"2002","journal-title":"FASEB J"},{"key":"10.1111\/bjd.12973-BIB0177|bjd12973-cit-0177","first-page":"1648","article-title":"Efficacy and toxicity of the angiogenesis inhibitor SU5416 as a single agent in patients with advanced renal cell carcinoma, melanoma, and soft tissue sarcoma","volume":"9","author":"Kuenen","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1111\/bjd.12973-BIB0178|bjd12973-cit-0178","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/sj.bjc.6603291","article-title":"Sorafenib in advanced melanoma: a Phase II randomised discontinuation trial analysis","volume":"95","author":"Eisen","year":"2006","journal-title":"Br J Cancer"},{"key":"10.1111\/bjd.12973-BIB0179|bjd12973-cit-0179","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1245\/s10434-007-9389-5","article-title":"A randomized phase 2 trial of bevacizumab with or without daily low-dose interferon alfa-2b in metastatic malignant melanoma","volume":"14","author":"Varker","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"10.1111\/bjd.12973-BIB0180|bjd12973-cit-0180","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1159\/000138351","article-title":"Preliminary results of the combination of bevacizumab and weekly paclitaxel in advanced melanoma","volume":"74","author":"Gonz\u00e1lez-Cao","year":"2008","journal-title":"Oncology"},{"key":"10.1111\/bjd.12973-BIB0181|bjd12973-cit-0181","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1200\/JCO.2007.14.8288","article-title":"Double-blind randomized phase II study of the combination of sorafenib and dacarbazine in patients with advanced melanoma: a report from the 11715 Study Group","volume":"26","author":"McDermott","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1111\/bjd.12973-BIB0182|bjd12973-cit-0182","doi-asserted-by":"crossref","first-page":"7711","DOI":"10.1158\/1078-0432.CCR-09-2074","article-title":"Phase II trial of temozolomide and sorafenib in advanced melanoma patients with or without brain metastases","volume":"15","author":"Amaravadi","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1111\/bjd.12973-BIB0183|bjd12973-cit-0183","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1200\/JCO.2007.15.7636","article-title":"Results of a phase III, randomized, placebo-controlled study of sorafenib in combination with carboplatin and paclitaxel as second-line treatment in patients with unresectable stage III or stage IV melanoma","volume":"27","author":"Hauschild","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1111\/bjd.12973-BIB0184|bjd12973-cit-0184","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/cncr.23987","article-title":"Phase 2 trial of carboplatin, weekly paclitaxel, and biweekly bevacizumab in patients with unresectable stage IV melanoma: a North Central Cancer Treatment Group study, N047A","volume":"115","author":"Perez","year":"2009","journal-title":"Cancer"},{"key":"10.1111\/bjd.12973-BIB0185|bjd12973-cit-0185","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1016\/j.ejca.2010.07.014","article-title":"A phase 2 study of vatalanib in metastatic melanoma patients","volume":"46","author":"Cook","year":"2010","journal-title":"Eur J Cancer"},{"key":"10.1111\/bjd.12973-BIB0186|bjd12973-cit-0186","doi-asserted-by":"crossref","first-page":"5862","DOI":"10.1158\/1078-0432.CCR-10-2363","article-title":"Bevacizumab plus fotemustine as first-line treatment in metastatic melanoma patients: clinical activity and modulation of angiogenesis and lymphangiogenesis factors","volume":"16","author":"Vecchio","year":"2010","journal-title":"Clin Cancer Res"},{"key":"10.1111\/bjd.12973-BIB0187|bjd12973-cit-0187","doi-asserted-by":"crossref","first-page":"4122","DOI":"10.1002\/cncr.25320","article-title":"Bevacizumab and everolimus in the treatment of patients with metastatic melanoma: a phase 2 trial of the Sarah Cannon Oncology Research Consortium","volume":"116","author":"Hainsworth","year":"2010","journal-title":"Cancer"},{"key":"10.1111\/bjd.12973-BIB0188|bjd12973-cit-0188","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1002\/cncr.24821","article-title":"A randomized phase 2 study of etaracizumab, a monoclonal antibody against integrin \u03b1V\u03b23, \u00b1 dacarbazine in patients with stage IV metastatic melanoma","volume":"116","author":"Hersey","year":"2010","journal-title":"Cancer"},{"key":"10.1111\/bjd.12973-BIB0189|bjd12973-cit-0189","doi-asserted-by":"crossref","first-page":"e15588","DOI":"10.1371\/journal.pone.0015588","article-title":"A phase II trial of sorafenib in metastatic melanoma with tissue correlates","volume":"5","author":"Ott","year":"2010","journal-title":"PLOS ONE"},{"key":"10.1111\/bjd.12973-BIB0190|bjd12973-cit-0190","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1097\/CMR.0b013e3283390365","article-title":"A phase II trial of bevacizumab with dacarbazine and daily low-dose interferon-alpha2a as first line treatment in metastatic melanoma","volume":"20","author":"Vihinen","year":"2010","journal-title":"Melanoma Res"},{"key":"10.1111\/bjd.12973-BIB0191|bjd12973-cit-0191","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1093\/annonc\/mdq648","article-title":"Sorafenib and pegylated interferon-\u03b12b in advanced metastatic melanoma: a multicenter phase II DeCOG trial","volume":"22","author":"Egberts","year":"2011","journal-title":"Ann Oncol"},{"key":"10.1111\/bjd.12973-BIB0192|bjd12973-cit-0192","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/bjc.2011.257","article-title":"Sorafenib and dacarbazine as first-line therapy for advanced melanoma: phase I trial and open-label phase II studies","volume":"105","author":"Eisen","year":"2011","journal-title":"Br J Cancer"},{"key":"10.1111\/bjd.12973-BIB0193|bjd12973-cit-0193","doi-asserted-by":"crossref","first-page":"7462","DOI":"10.1158\/1078-0432.CCR-11-0534","article-title":"Multicenter, phase II study of axitinib, a selective second-generation inhibitor of vascular endothelial growth factor receptors 1, 2 and 3, in patients with metastatic melanoma","volume":"17","author":"Fruehauf","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1111\/bjd.12973-BIB0194|bjd12973-cit-0194","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/CJI.0b013e31821dcefd","article-title":"A phase 2 trial of bevacizumab and high-dose interferon \u03b12B in metastatic melanoma","volume":"34","author":"Grignol","year":"2011","journal-title":"J Immunother"},{"key":"10.1111\/bjd.12973-BIB0195|bjd12973-cit-0195","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/bjc.2011.183","article-title":"A randomised, phase II study of intetumumab, an anti-\u03b1v-integrin mAb, alone and with dacarbazine in stage IV melanoma","volume":"105","author":"O'Day","year":"2011","journal-title":"Br J Cancer"},{"key":"10.1111\/bjd.12973-BIB0196|bjd12973-cit-0196","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1097\/CMR.0b013e32835312e4","article-title":"A randomized phase II study of cilengitide (EMD 121974) in patients with metastatic melanoma","volume":"22","author":"Kim","year":"2012","journal-title":"Melanoma Res"},{"key":"10.1111\/bjd.12973-BIB0197|bjd12973-cit-0197","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1200\/JCO.2011.34.6270","article-title":"BEAM: a randomized phase II study evaluating the activity of bevacizumab in combination with carboplatin plus paclitaxel in patients with previously untreated advanced melanoma","volume":"30","author":"Kim","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1111\/bjd.12973-BIB0198|bjd12973-cit-0198","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1093\/annonc\/mdr126","article-title":"First-line temozolomide combined with bevacizumab in metastatic melanoma: a multicentre phase II trial (SAKK 50\/07)","volume":"23","author":"Moos","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1111\/bjd.12973-BIB0199|bjd12973-cit-0199","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1002\/cncr.27760","article-title":"A randomized phase 2 study of temozolomide and bevacizumab or nab-paclitaxel, carboplatin, and bevacizumab in patients with unresectable stage IV melanoma: a North Central Cancer Treatment Group study, N0775","volume":"119","author":"Kottschade","year":"2013","journal-title":"Cancer"},{"key":"10.1111\/bjd.12973-BIB0200|bjd12973-cit-0200","first-page":"419","article-title":"The prognostic significance of tumour vascularity in intermediate-thickness (0.76-4.0\u00a0mm thick) skin melanoma. A quantitative histologic study","volume":"133","author":"Srivastava","year":"1988","journal-title":"Am J Pathol"},{"key":"10.1111\/bjd.12973-BIB0201|bjd12973-cit-0201","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/bjc.1989.17","article-title":"Vascularity in cutaneous melanoma detected by Doppler sonography and histology: correlation with tumour behaviour","volume":"59","author":"Srivastava","year":"1989","journal-title":"Br J Cancer"},{"key":"10.1111\/bjd.12973-BIB0202|bjd12973-cit-0202","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/00008390-199902000-00008","article-title":"Prognostic value of tumour vascularity in metastatic melanoma and association of blood vessel density with vascular endothelial growth factor expression","volume":"9","author":"Vlaykova","year":"1999","journal-title":"Melanoma Res"},{"key":"10.1111\/bjd.12973-BIB0203|bjd12973-cit-0203","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1002\/path.988","article-title":"PAS-positive loops and networks as a prognostic indicator in cutaneous malignant melanoma","volume":"195","author":"Thies","year":"2001","journal-title":"J Pathol"},{"key":"10.1111\/bjd.12973-BIB0204|bjd12973-cit-0204","first-page":"473","article-title":"Prognostic significance of periodic acid-Schiff-positive patterns in primary cutaneous melanoma","volume":"7","author":"Warso","year":"2001","journal-title":"Clin Cancer Res"},{"key":"10.1111\/bjd.12973-BIB0205|bjd12973-cit-0205","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1046\/j.1365-2230.2002.00976.x","article-title":"Expression of endoglin in human melanocytic lesions","volume":"27","author":"Dawn","year":"2002","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/bjd.12973-BIB0206|bjd12973-cit-0206","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.2214\/ajr.178.6.1781547","article-title":"Prognostic value of angiogenesis evaluated with high-frequency and color Doppler sonography for preoperative assessment of melanomas","volume":"178","author":"Lassau","year":"2002","journal-title":"AJR Am J Roentgenol"},{"key":"10.1111\/bjd.12973-BIB0207|bjd12973-cit-0207","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s004280100480","article-title":"Tumor angiogenesis as a prognostic factor in thick cutaneous malignant melanoma. A quantitative morphologic analysis","volume":"440","author":"Massi","year":"2002","journal-title":"Virchows Arch"},{"key":"10.1111\/bjd.12973-BIB0208|bjd12973-cit-0208","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1016\/S0002-9440(10)64328-3","article-title":"Tumor lymphangiogenesis: a novel prognostic indicator for cutaneous melanoma metastasis and survival","volume":"162","author":"Dadras","year":"2003","journal-title":"Am J Pathol"},{"key":"10.1111\/bjd.12973-BIB0209|bjd12973-cit-0209","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1046\/j.1365-2362.2003.01152.x","article-title":"Tumor vascularity and tryptase-positive mast cells correlate with a poor prognosis in melanoma","volume":"33","author":"Ribatti","year":"2003","journal-title":"Eur J Clin Invest"},{"key":"10.1111\/bjd.12973-BIB0210|bjd12973-cit-0210","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.humpath.2003.10.022","article-title":"Vasculogenic mimicry has no prognostic significance in pT3 and pT4 cutaneous melanoma","volume":"35","author":"Massi","year":"2004","journal-title":"Hum Pathol"},{"key":"10.1111\/bjd.12973-BIB0211|bjd12973-cit-0211","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1102\/1470-7330.2006.0009","article-title":"Prognostic value of angiogenesis evaluated with high-frequency and colour Doppler sonography for preoperative assessment of primary cutaneous melanomas: correlation with recurrence after a 5\u00a0year follow-up period","volume":"6","author":"Lassau","year":"2006","journal-title":"Cancer Imaging"},{"key":"10.1111\/bjd.12973-BIB0212|bjd12973-cit-0212","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/BF02893437","article-title":"Association of microvessel density with infiltrating cells in human cutaneous malignant melanoma","volume":"13","author":"Kiss","year":"2007","journal-title":"Pathol Oncol Res"},{"key":"10.1111\/bjd.12973-BIB0213|bjd12973-cit-0213","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1007\/s12262-011-0398-z","article-title":"Doppler ultrasound flowmetry predicts 15\u00a0year outcome in patients with skin melanoma","volume":"74","author":"Srivastava","year":"2012","journal-title":"Indian J Surg"},{"key":"10.1111\/bjd.12973-BIB0214|bjd12973-cit-0214","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/modpathol.2011.182","article-title":"Objective assessment of blood and lymphatic vessel invasion and association with macrophage infiltration in cutaneous melanoma","volume":"25","author":"Storr","year":"2012","journal-title":"Mod Pathol"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbjd.12973","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/bjd.12973\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T08:53:15Z","timestamp":1689065595000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/171\/2\/220\/6615660"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,26]]},"references-count":214,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,8]]}},"URL":"https:\/\/doi.org\/10.1111\/bjd.12973","relation":{},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7,26]]}}}